Dose-Escalation and Safety Trial of YN968D1

Clinical trial NCT01497704 · COMPLETED

Trial details

NCT number: NCT01497704
Sponsor: Elevar Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Patients With Solid Tumors

Start date: 2012-04-01
Primary completion: 2015-02-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.